PHARMACOLOGICAL INHIBITION OF TFF3 ENHANCES SENSITIVITY-AND OVERCOMES ACQUIRED RESISTANCE-TO DOXORUBICIN IN ESTROGEN RECEPTOR-POSITIVE BREAST CANCER

Ph.D

Saved in:
Bibliographic Details
Main Author: POH HAN MING
Other Authors: PHARMACOLOGY
Format: Theses and Dissertations
Language:English
Published: 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/170803
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
id sg-nus-scholar.10635-170803
record_format dspace
spelling sg-nus-scholar.10635-1708032020-07-01T13:23:44Z PHARMACOLOGICAL INHIBITION OF TFF3 ENHANCES SENSITIVITY-AND OVERCOMES ACQUIRED RESISTANCE-TO DOXORUBICIN IN ESTROGEN RECEPTOR-POSITIVE BREAST CANCER POH HAN MING PHARMACOLOGY Alan Prem Kumar Peter Edward Lobie Lee Soo Chin Breast cancer, Doxorubicin, Trefoil Factor 3, Dose-dependent toxicity, Apoptosis, Acquired resistance Ph.D DOCTOR OF PHILOSOPHY (SOM) 2020-06-30T18:01:10Z 2020-06-30T18:01:10Z 2019-08-22 Thesis POH HAN MING (2019-08-22). PHARMACOLOGICAL INHIBITION OF TFF3 ENHANCES SENSITIVITY-AND OVERCOMES ACQUIRED RESISTANCE-TO DOXORUBICIN IN ESTROGEN RECEPTOR-POSITIVE BREAST CANCER. ScholarBank@NUS Repository. https://scholarbank.nus.edu.sg/handle/10635/170803 0000-0001-7197-7917 en
institution National University of Singapore
building NUS Library
country Singapore
collection ScholarBank@NUS
language English
topic Breast cancer, Doxorubicin, Trefoil Factor 3, Dose-dependent toxicity, Apoptosis, Acquired resistance
spellingShingle Breast cancer, Doxorubicin, Trefoil Factor 3, Dose-dependent toxicity, Apoptosis, Acquired resistance
POH HAN MING
PHARMACOLOGICAL INHIBITION OF TFF3 ENHANCES SENSITIVITY-AND OVERCOMES ACQUIRED RESISTANCE-TO DOXORUBICIN IN ESTROGEN RECEPTOR-POSITIVE BREAST CANCER
description Ph.D
author2 PHARMACOLOGY
author_facet PHARMACOLOGY
POH HAN MING
format Theses and Dissertations
author POH HAN MING
author_sort POH HAN MING
title PHARMACOLOGICAL INHIBITION OF TFF3 ENHANCES SENSITIVITY-AND OVERCOMES ACQUIRED RESISTANCE-TO DOXORUBICIN IN ESTROGEN RECEPTOR-POSITIVE BREAST CANCER
title_short PHARMACOLOGICAL INHIBITION OF TFF3 ENHANCES SENSITIVITY-AND OVERCOMES ACQUIRED RESISTANCE-TO DOXORUBICIN IN ESTROGEN RECEPTOR-POSITIVE BREAST CANCER
title_full PHARMACOLOGICAL INHIBITION OF TFF3 ENHANCES SENSITIVITY-AND OVERCOMES ACQUIRED RESISTANCE-TO DOXORUBICIN IN ESTROGEN RECEPTOR-POSITIVE BREAST CANCER
title_fullStr PHARMACOLOGICAL INHIBITION OF TFF3 ENHANCES SENSITIVITY-AND OVERCOMES ACQUIRED RESISTANCE-TO DOXORUBICIN IN ESTROGEN RECEPTOR-POSITIVE BREAST CANCER
title_full_unstemmed PHARMACOLOGICAL INHIBITION OF TFF3 ENHANCES SENSITIVITY-AND OVERCOMES ACQUIRED RESISTANCE-TO DOXORUBICIN IN ESTROGEN RECEPTOR-POSITIVE BREAST CANCER
title_sort pharmacological inhibition of tff3 enhances sensitivity-and overcomes acquired resistance-to doxorubicin in estrogen receptor-positive breast cancer
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/170803
_version_ 1681101322846208000